Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.20%
1,108.23
-2.24
-0.20%
1,110.471,107.751,111.341,093.81
SIXC
Communications
SIXC
Communications
SIXC
+0.26%
605.63
+1.56
+0.26%
604.07604.07606.04600.91
SIXE
Energy
SIXE
Energy
SIXE
+0.70%
1,209.95
+8.46
+0.70%
1,201.491,205.921,215.311,201.02
SIXI
Industrials
SIXI
Industrials
SIXI
-0.40%
1,758.23
-7.07
-0.40%
1,765.301,764.031,764.031,736.40
SIXM
Financials
SIXM
Financials
SIXM
+0.72%
634.94
+4.52
+0.72%
630.42630.34636.69626.03
SIXR
Staples
SIXR
Staples
SIXR
+1.30%
852.37
+10.92
+1.30%
841.45843.60858.11840.11
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.01%
218.85
+0.020
+0.01%
218.83218.83219.32217.33
SIXT
Technology
SIXT
Technology
SIXT
-1.50%
3,528.49
-53.74
-1.50%
3,582.233,550.603,562.623,447.78
SIXU
Utilities
SIXU
Utilities
SIXU
+0.10%
914.82
+0.93
+0.10%
913.89912.75918.12906.67
SIXV
Health care
SIXV
Health care
SIXV
+1.93%
1,472.27
+27.94
+1.93%
1,444.331,446.871,480.741,446.30
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.93%
2,390.61
-22.35
-0.93%
2,412.962,403.992,411.412,373.90
CRLBF:OTCMKTS
Cresco Labs Inc
$0.95
-5.66%
(-0.057) 1D
May 12, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CRLBF...
Open
$1.00
High
$1.01
Low
$0.95
Mkt. cap
455.36M
Avg. vol.
919.60K
Volume
528.53K
52-wk high
$2.30
52-wk low
$0.43
Beta
1.26
Shares outstanding
343.23M
No. of employees
3K
News stories
From sources across the web
Profile
Cresco Labs, Inc. is a publicly traded, vertically integrated cannabis and medical marijuana company based in Chicago, Illinois, with current retail operations in nine states where marijuana has been legalized for medical use. The company's stock trades on the Canadian Securities Exchange under the ticker symbol CL, and in over-the-counter markets in the United States with the ticker symbol CRLBF. Wikipedia
About Cresco Labs Inc
CEO-
Employees2.9K
Founded2013
HeadquartersChicago, Illinois, United States
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
166.12M
164.91M
161.55M
151.32M
Cost of goods sold
80.37M
85.55M
78.23M
75.88M
Cost of revenue
80.37M
85.55M
78.23M
75.88M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
56.00M
53.53M
60.43M
64.28M
Operating expense
60.34M
59.17M
65.40M
64.28M
Total operating expenses
140.71M
144.72M
143.63M
140.15M
Operating income
25.41M
20.19M
17.92M
11.17M
Other non operating income
442.00K
4.21M
4.23M
960.00K
EBT including unusual items
2.74M
-10.10M
-87.15M
-2.79M
EBT excluding unusual items
12.68M
10.06M
7.62M
-2.79M
Income tax expense
16.64M
11.87M
1.80M
14.22M
Effective tax rate
606.30%
-117.48%
-2.07%
-508.95%
Other operating expenses
-
-
-
-
Net income
-16.33M
-17.05M
-87.59M
-13.07M
Net profit margin
-9.83%
-10.34%
-54.22%
-8.64%
Earnings per share
-0.02
0.01
-0.03
-0.04
Interest and investment income
935.00K
699.00K
1.30M
-
Interest expense
-13.50M
-15.27M
-15.63M
-14.93M
Net interest expenses
-12.56M
-14.57M
-14.33M
-14.93M
Depreciation and amortization charges
4.42M
5.64M
4.97M
-
EBITDA
37.60M
33.05M
28.68M
23.39M
Gain or loss from assets sale
658.00K
-2.60M
352.00K
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more